Cargando…
Efficacy of ribavirin against malignant glioma cell lines: Follow-up study
Ribavirin, a nucleic acid analog, has been employed as an antiviral agent against RNA and DNA viruses and has become the standard agent used for chronic hepatitis C in combination with interferon-α2a. Furthermore, the potential antitumor efficacy of ribavirin has attracted increasing interest. Recen...
Autores principales: | Ochiai, Yushi, Sano, Emiko, Okamoto, Yutaka, Yoshimura, Sodai, Makita, Kotaro, Yamamuro, Shun, Ohta, Takashi, Ogino, Akiyoshi, Tadakuma, Hisashi, Ueda, Takuya, Nakayama, Tomohiro, Hara, Hiroyuki, Yoshino, Atsuo, Katayama, Yoichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783620/ https://www.ncbi.nlm.nih.gov/pubmed/29251333 http://dx.doi.org/10.3892/or.2017.6149 |
Ejemplares similares
-
Antitumor effects of ribavirin in combination with TMZ and IFN-β in malignant glioma cells
por: Ochiai, Yushi, et al.
Publicado: (2020) -
Efficacy of ribavirin against malignant glioma cell lines
por: OGINO, AKIYOSHI, et al.
Publicado: (2014) -
Characterization of glioma stem-like cells from human glioblastomas
por: YAMAMURO, SHUN, et al.
Publicado: (2015) -
Antitumorigenic effect of interferon-β by inhibition of undifferentiated glioblastoma cells
por: YAMAMURO, SHUN, et al.
Publicado: (2015) -
IFN-β sensitizes TRAIL-induced apoptosis by upregulation of death receptor 5 in malignant glioma cells
por: Yoshimura, Sodai, et al.
Publicado: (2019)